Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-methionine (R)-S-oxide is the R-diastereomer of methionine sulfoxide, an oxidized derivative of the essential amino acid methionine. It is a small molecule and belongs to the class of L-alpha-amino acids. This compound arises through oxidation of methionine residues in proteins by reactive oxygen species, resulting in a mixture of S and R diastereomers. In biological systems, it serves as a metabolite found in or produced by Escherichia coli and yeast[1][6][7]. The reduction back to methionine is catalyzed by specific enzymes such as methionine sulfoxide reductase B for the R-form[5][6]. Methionine sulfoxides are not incorporated into proteins during translation but can accumulate under oxidative stress conditions and may serve as markers for oxidative damage or aging[5]. Experimentally, it has been studied as an inhibitor of amyloid-beta precursor protein[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-methionine (R)-S-oxide.